相关实验视频

Updated: Jun 23, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

介质素-6在各种癌症的进展和治疗中起到关键作用

Asma'a H Mohamed¹, Abdulrahman T Ahmed², Waleed Al Abdulmonem³

¹Biomedical Engineering Department, College of Engineering and Technologies, Al-Mustaqbal University, Babil, Hilla, 51001, Iraq.

Medical oncology (Northwood, London, England)

|June 20, 2024

概括

互白素-6 (IL-6) 通过其信号通路驱动癌症的进展. 抑制IL-6信号显示为针对多种癌症类型的向治疗具有前途,提供新的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

介乐-6 (IL-6) 是一种促炎性细胞因子,对免疫防御和应激反应至关重要.
通过IL-6信号传递,特别是通过STAT3和JAK2,影响细胞过程,如增殖和亡.
失调的IL-6与癌症有关,促进瘤发生和所有癌症特征.

研究的目的:

提供IL-6在各种癌症中的作用的概述.
讨论针对癌症治疗IL-6信号的临床前和临床研究.

主要方法:

关于IL-6在癌症中的信号传递的文献综述.
针对IL-6通路组件 (IL-6Rs,gp130,STAT3,JAK) 的治疗策略的分析.

主要成果:

IL-6信号传递有助于关键的癌症特征,包括生存,增殖和转移.
目前正在研究用单克隆抗体或小分子向IL-6信号传递.
在多发性骨髓瘤和各种固体瘤中观察到IL-6通路抑制的治疗益处.

结论:

IL-6在促进癌症的发展和进展方面发挥着重要作用.
准IL-6信号通路代表了对各种恶性瘤的有希望的治疗策略.
对各种癌症类型的IL-6向疗法的进一步研究是有必要的.

关键词:

癌症癌症癌症癌症在IL-6的研究中,IL-6被认为是IL-6的基因.炎症性细胞因子是炎症性细胞因子.在STAT3中,我们可以使用STAT3.有针对性的治疗.

更多相关视频

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...